Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Active

Bill · 119th Congress · S 272

Protect Infant Formula from Contamination Act

Refreshed 1 h ago

Introduced 2025-01-28Topic: public health · agriculture food

Summary

Summary by the Congressional Research Service

Protect Infant Formula from Contamination Act This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-05-04HouseHeld at the desk.
2026-05-04HouseReceived in the House.
2026-05-01SenateMessage on Senate action sent to the House.
2026-04-28SenatePassed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S2074-2075; text: CR S2074)
2026-04-28Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.floor pass
2026-01-28SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 306.
2026-01-28SenateCommittee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.refer
2026-01-28Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.report
2026-01-15SenateCommittee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.refer
2025-01-28SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.refer
2025-01-28Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-20. Provisions and opinion polling arrive in a later release.